SCHEMBL4674606

SCHEMBL4674606

Nc1ccc(F)cc1C(=O)C1CC[N]CC1

nearest known ligand 0.51

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 1/20 0.51
HSD11B1 P28845 4/20 0.41
FADS1 O60427 1/20 0.38
ALDH1A1 P00352 4/20 0.38
HDAC3 O15379 3/20 0.37
HDAC1 Q13547 3/20 0.37
HDAC2 Q92769 3/20 0.37
MAPT P10636 1/20 0.37
NPY2R P49146 1/20 0.37
CES2 O00748 1/20 0.36
CES1 P23141 1/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
L3MBTL1 Q9Y468 1/20 0.35
PIN1 Q13526 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8535843 0.89 KEAP1 (0.59) KEAP1HSD11B1FADS1ALDH1A1HDAC3
SCHEMBL1342200 0.86 KEAP1 (0.56) KEAP1HSD11B1FADS1ALDH1A1HDAC3
SCHEMBL5278682 0.84 KEAP1 (0.54) KEAP1HSD11B1FADS1ALDH1A1HDAC3
SCHEMBL4674613 0.83 KEAP1 (0.53) KEAP1HSD11B1FADS1HDAC3HDAC1
SCHEMBL4672823 0.81 CES2 (0.50) HSD11B1ALDH1A1MAPTNPY2RCES2
SCHEMBL11749982 0.79 HTR1F (0.52) KEAP1HSD11B1ALDH1A1HDAC3HDAC1
SCHEMBL4673461 0.79 GAA (0.39) HSD11B1ALDH1A1MAPTNPY2RCES2
SCHEMBL8105872 0.77 KEAP1 (0.46) KEAP1HSD11B1ALDH1A1HDAC3HDAC1
SCHEMBL8917695 0.75 HSD11B1 (0.47) HSD11B1ALDH1A1MEN1KMT2APIN1
SCHEMBL8105870 0.75 ALDH1A1 (0.39) KEAP1HSD11B1ALDH1A1HDAC3HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0958287-B2 SULFAMIDE-METALLOPROTEASE INHIBITORS HOFFMANN LA ROCHE (CH) 2008-04-09 EP disclosed
EP-0958287-B1 SULFAMIDE-METALLOPROTEASE INHIBITORS HOFFMANN LA ROCHE (CH) 2002-09-11 EP disclosed
US-6376506-B1 REACTING SULFAMOYL OXAZOLIDONE WITH (1,2,3,4)-TETRAHYDRO-BETA-CARBOLINE TO FORM INHIBITOR; USED TO TREAT ARTHRITIS, OSTEOPOROSIS, PERIODONTAL DISEASE, CARDIOVASCULAR DISEASES, MULTIPLE SCLEROSIS, AND TUMORS SYNTEX (U.S.A.) LLC 2002-04-23 US disclosed